My Tiny Feed

abcnews.go.com

Huntington's Disease: CAG Repeat Expansion Identified as Key Disease Mechanism

New research shows that the Huntington's disease mutation, involving a repeated DNA sequence (CAG), expands over time, remaining harmless until it surpasses 150 repeats, triggering toxic protein production and neuronal death; this discovery could lead to new treatment strategies.

Read original article in English

English

United States

HealthScienceScientific BreakthroughNeurodegenerative DiseaseGenetic MutationHuntington's DiseaseCag RepeatsDna Expansion

Broad Institute Of Mit And HarvardMclean HospitalHarvard Medical SchoolHoward Hughes Medical InstituteAlbert Einstein College Of Medicine

Mark MehlerSteve MccarrollSabina Berretta

What is the key mechanism by which the Huntington's disease mutation causes neuronal damage, and what is its clinical significance?: Huntington's disease, a fatal hereditary disorder, is caused by a genetic mutation where a DNA sequence (CAG) repeats at least 40 times. This mutation remains harmless for decades but expands over time, eventually exceeding a threshold of about 150 repeats, leading to toxic protein production and neuronal death.
How do the study's findings challenge previous understandings of the Huntington's disease mutation's progression, and what implications does this have for treatment strategies?: The study, analyzing 53 Huntington's patients and 50 controls, revealed that CAG repeat expansion accelerates dramatically after reaching around 80 repeats. This expansion correlates with the age of disease onset; longer repeats lead to earlier onset. The findings challenge previous assumptions about the mutation's role.
What are the potential long-term implications of this research for developing effective therapies for Huntington's disease, considering the challenges faced by current treatment approaches?: The research suggests that slowing or stopping CAG repeat expansion, rather than solely targeting the toxic protein, could be a more effective treatment strategy for Huntington's disease. Pharmaceutical companies are already exploring this approach, offering hope for delaying or preventing the disease.

Sustainable Development Goals

Good Health and Well-being Positive

Direct Relevance

The research contributes to a better understanding of Huntington's disease, paving the way for potential treatments and improved management of the condition. This directly aligns with SDG 3, which aims to ensure healthy lives and promote well-being for all at all ages.

Jan 23, 01:10

Microplastics Linked to Brain Blood Clots, Raising Dementia and Stroke Risks

A Peking University study reveals microplastics in the brain trigger immune responses, causing blood clots that may lead to stroke, depression, and possibly dementia; further research is needed.

Jan 23, 01:10

Rare Gene Mutation Linked to Late-Onset Alzheimer's

A study of an Italian family with six members affected by late-onset Alzheimer's disease reveals a rare mutation in the GRIN2C gene as a probable cause, offering a significant advancement in understanding the disease's genetic basis.

Jan 22, 13:12

Surge in Four Viruses Strains US Healthcare Systems

Four viruses (influenza, COVID-19, RSV, and norovirus) are surging in the U.S., causing widespread illness and impacting healthcare systems, with the CDC reporting high positivity rates and increased hospital visits; vaccines are available for some, but not all, of the viruses.

Jan 22, 04:12

Physical Fitness Linked to Lower Cancer Mortality Risk

A study of nearly 47,000 cancer patients found that muscular strength and cardiorespiratory fitness were associated with a 31–46% lower risk of death from any cause, with even greater reductions in specific cancer types and stages; this research, published in the British Journal of Sports Medicine, suggests tailored exercise plans may improve survival rates.